Searched for
GLAND PHARMA REVENUE
Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...- Cenexi recovery, new product launches and capacity additions power Gland Pharma outlookGland Pharma stock surged to a 52-week high following robust March quarter and full-year results. Its European unit, Cenexi, is improving p...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Gland Pharma shares jump 11% as Q4 profit soars 97% YoY, co announces Rs 20/share final dividendShares of Gland Pharma rallied on Monday after the company reported a 97% YoY surge in Q4 profit and strong revenue growth, driven by its C...
- Gland Pharma Q2 Results: Profit rises 12% to Rs 184 croreGland Pharma on Monday reported 12 per cent year-on-year increase in profit after tax (PAT) at Rs 184 crore for the September quarter, aide...
- Gland Pharma Q4 Results: Net profit down 3% at Rs 186 croreGland Pharma Ltd on Tuesday reported a 3 per cent decline in consolidated net profit to Rs 186.54 crore in the fourth quarter ended March 3...
- Gland Pharma shares fall over 4% after weak Q3 result, Jefferies target price cutGland Pharma share price: Revenue from operations fell 10% year-on-year to Rs 1,384 crore. EBITDA increased by 1% year-on-year to Rs 360 cr...
- Gland Pharma Q3 net profit rises 7% to Rs 205 croreGland Pharma on Monday reported 7% year-on-year (YoY) rise in net profit to Rs 205 crores in Q3FY25.
- Gland Pharma shares zoom 12% post Q2 results; Kotak upgrades on limited downsideGland Pharma Share Price: Gland Pharma shares rose 12% despite a 15.7% YoY profit decline in Q2. Kotak upgraded the stock to 'Reduce' with ...
- Buy Gland Pharma, target price Rs 2440: Motilal OswalGland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 34712.36 Crore) operating in Pharmaceut...
- Gland Pharma Q1 profit dips 26% to Rs 144 croreGland Pharma on Tuesday said its profit after tax declined by 26 per cent to Rs 144 crore for the first quarter ended June 30, 2024. The Hy...
- Buy Gland Pharma, target price Rs 2240: Motilal OswalGland Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Other Operating Revenue and Export Incentives fo...
- Buy Gland Pharma, target price Rs 1920: Motilal OswalGland Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Other Operating Revenue and Export Incentives fo...
- Gland Pharma stock declines 2 pc after earnings announcementGland Pharma Ltd on Monday reported a 15 per cent decline in consolidated net profit at Rs 231.95 crore for the third quarter ended Decembe...
- Gland says not heard from its promoter Fosun about the potential saleThe debt-laden Chinese conglomerate Fosun controlled by billionaire entrepreneur Guo Guangchang has been looking to sell non-core assets, t...
- Hold Gland Pharma, target price Rs 2100: Axis SecuritiesGland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 31075.06 Crore) operating in Pharmaceut...
- 4 reasons analysts are bullish on Gland Pharma stockGrowth of injectables in the pharmaceutical market, strong R&D capabilities and the probablity of starting a business with China that has a...
- Smartkarma Research: APAC Healthcare Series - Top picks are poised for multi-year growthGland Pharma’s near-term focus remains on establishing a strong portfolio of complex injectables. The company is working on development of ...
- Gland Pharma Q1 results: Net profit rises 12% to Rs 351 crConsolidated revenue from operations of the company stood at Rs 1,153.9 crore for the quarter under consideration. It was Rs 884.2 crore fo...
Load More
